XML 49 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Sep. 30, 2012
Oct. 02, 2011
Cash flows provided by operating activities:    
Net Income (loss) $ (4,388) $ 51,901
Adjustments:    
Depreciation 9,601 9,570
Amortization of intangible assets 10,467 8,123
Gain from divestitures (886) (45,939)
Stock-based compensation expense, net of amounts capitalized in inventory 6,532 8,149
Deferred tax provision (4,297) (2)
Tax benefit from share based payment arrangements (45) 0
Changes in assets and liabilities (net of amounts acquired):    
Accounts receivable, net (6,563) 5,358
Inventories 11,846 (12,628)
Prepayments and other assets 6,976 2,958
Accounts payable (782) (5,879)
Accrued compensation and related expenses (4,962) (196)
Deferred income on shipments to distributors 169 3,180
Income taxes payable and receivable 26 1,136
Other accrued liabilities and long-term liabilities 1,063 (2,795)
Net cash provided by operating activities 24,757 22,936
Cash flows provided by (used for) investing activities:    
Acquisitions, net of cash acquired (68,341) 0
Cash in escrow related to acquisitions (7,816) 0
Proceeds from divestitures 5,000 51,670
Purchases of property, plant and equipment, net (17,263) (13,322)
Purchases of short-term investments (92,150) (310,494)
Proceeds from sales of short-term investments 27,162 220,163
Proceeds from maturities of short-term investments 84,690 98,068
Net cash provided by (used for) investing activities (68,718) 46,085
Cash flows provided by (used for) financing activities:    
Proceeds from issuance of common stock 6,138 7,679
Repurchase of common stock 0 (47,465)
Excess tax benefit from share based payment arrangements 45 0
Net cash provided by (used for) financing activities 6,183 (39,786)
Effect of exchange rates on cash and cash equivalents 725 (524)
Net increase (decrease) in cash and cash equivalents (37,053) 28,711
Cash and cash equivalents at beginning of period 134,924 104,680
Cash and cash equivalents at end of period $ 97,871 $ 133,391